Affiliation:
1. Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
2. Research, Development and Innovation Center, Tampere University Hospital, Tampere, Finland
Abstract
The prognosis of local prostate cancer has improved drastically during the past 60 years. Similarly, the prognosis in metastatic stage is constantly improving due to a number of new pharmaceuticals introduced over the past 10 years. Previously, only palliative treatments were available for prostate cancer, but today, there are multiple options for treatment with curative intent: robotic-assisted radical prostatectomy, stereotactic radiotherapy and brachytherapy. Additionally, life-prolonging chemotherapeutic and androgen-suppressive treatments, as well as diagnostic imaging and staging, have improved considerably. This review summarizes the history of the treatment and diagnostics of prostate cancer, with a focus on the past 60 years. The aim was to provide a concise and easy-to-read introduction on the matter for all people that work with prostate cancer, as well as for patients. The literature was thoroughly examined covering the period from the earliest traceable records to the latest state-of-the-art studies.
Reference121 articles.
1. Trends in Prostate Cancer Survival in Sweden, 1960 Through 1988: Evidence of Increasing Diagnosis of Nonlethal Tumors
2. Finnish Cancer Registry. Cancer statistics [Internet]. https://cancerregistry.fi/statistics/cancer-statistics/ (2022, accessed 3 February 2023).
3. Ayobi S, Johansson E, Toorell N, et al. Cancer i siffror 2018: Populärvetenskapliga fakta om cancer [in Swedish] [Internet]. https://www.cancerfonden.Se/cancer-i-siffror (2018, accessed 3 February 2023).
4. A history of prostate cancer treatment
5. The history of the prostate, part one: say what you see